Trial Profile
Liraglutide and prevention of bone loss during weight loss maintenance
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 27 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.